Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Your PlexusDx clinician ensures correct dosing and monitors your progress
Featured Expert Mark Graber, JD Carey School of Law Source: WBAL Radio More Thyroid Cancers Found After Starting GLP-1s: Researchers Think They Know Why January 24, 2025 Of over 350,000 adults with type 2 diabetes, thyroid cancer risk was significantly higher within the first year after GLP-1 agonist initiation compared with SGLT2 inhibitors, DPP-4 inhibitors, or sulfonylureas (HR 1.85, 95% CI 1.11-3.08), reported Rozalina McCoy, MD, MS, of the University of Maryland School of Medicine in Baltimore, and colleagues
Clinical trial enrollment offers the highest quality access but the least predictability
Safety advice Check with a clinician before use if you are pregnant or breastfeeding, have diabetes or frequent low blood sugar, have a bleeding disorder, or have liver or kidney disease
Liraglutide activates the Nrf2/HO-1 antioxidant pathway and protects brain nerve cells against cerebral ischemia in diabetic rats
